A Novel Non-viral Cargo Delivery Platform: The First in a New Class

What will you learn from this webinar:

• Introducing CyGenica's GEENIE technology: A novel non viral delivery platform
• Potential applications of GEENIE
• Collaboration and partnering opportunities

Webinar Programme:

• 15.00 Welcome and introduction by CRISPR Medicine News
• 15.05 Dr. Nusrat J M Sanghamitra, Founder, CEO/CSO, Dr. Kaustuv Mittra, Research Scientist | GEENIE: The First in a New Class of Non-viral Delivery Platform for Cancer and Genome Editing Molecules
• 15.50 Q & A with Nusrat J M Sanghamitra
• 16.25 Close by CRISPR Medicine News

Speakers:

Dr. Nusrat J M Sanghamitra, Founder, CEO/CSO

Dr. Kaustuv Mittra, Research Scientist

Title:

GEENIE: The First in a New Class of Non-viral Delivery Platform for Cancer and Genome Editing Molecules

CMN interview

Dr Nusrat J M Sanghamitra

Nusrat is a scientist turned entrepreneur, committed to make a difference in people's life by her scientific and personal endeavors. She started her research journey with a mission 'to find a better anticancer drug with fewer side effects'. She is a chemist by training with a fascination for biology. Her research has been well cited. After actively pursuing research at the institutes of International repute, she founded CyGenica (Previously CyCa OncoSolutions) to translate her ideas and research (at the interface of chemistry, biomaterials, cell biology and its applications in anticancer drug development) from bench to bedside, to make an impact in oncology and to make significant contribution to the global fight against cancer. She is the recipient of National Award in 2018 from the honorable President of India for developing a technology having commercialization potential. She was nominated as the most innovative Business Woman of the year 2018 by Pharma Leaders India. She is also the recipient of Leaders of Innovation Fellowship 2021 by Royal Academy of Engineering London.

CMN interview